Category : Miscellaneous
 China’s National Medical Products Administration has officially approved an indigenously developed Alzheimer’s drug called GV-971 (sodium oligo-mannurarate). The Shanghai Institute of Materia Medica (SIMM) under the Chinese Academy of Sciences, which has developed the drug jointly with the Ocean University of China and Green Valley Pharmaceutical Co Ltd, after 22 years of research. Extracted from brown algae, the oral drug is the world’s first multi-targeting and carbohydrate-based drug, which will now be available to patients from December,29,2019. |
| Source: The Times of India |
You need to login to perform this action.
You will be redirected in
3 sec
